Chugai Pharmaceutical Co.
Japanese pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Chugai Pharmaceutical Co.?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014.[1] The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
Quick Facts Native name, Romanized name ...
Native name | 中外製薬株式会社 |
---|---|
Romanized name | Chūgai Seiyaku kabushiki gaisha |
Company type | Public KK |
| |
Industry | Pharmaceutical Industry, Business import, production and development of drugs for medical sales |
Founded | March 8, 1943; 81 years ago (1943-03-08) |
Headquarters | Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo On the registration Headquarter: Tokyo Kita (Tokyo) |
Key people | Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO |
Revenue | 72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated (December 2007) |
Parent | Hoffmann-La Roche (61.62%) |
Website | www |
Close